{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:39:25Z","timestamp":1790221165248,"version":"4.1.0"},"reference-count":95,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007612","name":"Animal Health Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007612","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.vaccine.2019.09.106","type":"journal-article","created":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T07:51:26Z","timestamp":1571212286000},"page":"388-398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Vaccination of foals with a modified live, equid herpesvirus-1 gM deletion mutant (RacH\u0394gM) confers partial protection against infection"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2648-6999","authenticated-orcid":false,"given":"Julia H.","family":"Kydd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0792-7418","authenticated-orcid":false,"given":"Duncan","family":"Hannant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaus","family":"Osterrieder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.09.106_b0005","series-title":"Equine Infectious Diseases VIII 1999","first-page":"129","article-title":"Advances in the understanding of the pathogenesis, epidemiology and immunological control of Equine herpesvirus abortion","author":"Allen","year":"1999"},{"key":"10.1016\/j.vaccine.2019.09.106_b0010","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.2042-3306.1993.tb02898.x","article-title":"An immunohistological study of the uterus of mares following experimental infection by equid herpesvirus 1","volume":"25","author":"Smith","year":"1993","journal-title":"Equine Vet J"},{"key":"10.1016\/j.vaccine.2019.09.106_b0015","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF01314149","article-title":"Endothelial cell infection and thrombosis in paralysis caused by equid herpesvirus-1: equine stroke","volume":"90","author":"Edington","year":"1986","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2019.09.106_b0020","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.vetimm.2006.01.005","article-title":"The equine immune response to equine herpesvirus-1: the virus and its vaccines","volume":"111","author":"Kydd","year":"2006","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2019.09.106_b0025","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.virol.2019.03.014","article-title":"Intranasal IgG4\/7 antibody responses protect horses against equid herpesvirus-1 (EHV-1) infection including nasal virus shedding and cell-associated viremia","volume":"531","author":"Perkins","year":"2019","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2019.09.106_b0030","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.vetmic.2013.06.018","article-title":"Equine herpesviruses type 1 (EHV-1) and 4 (EHV-4)\u2013masters of co-evolution and a constant threat to equids and beyond","volume":"167","author":"Ma","year":"2013","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.09.106_b0035","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.vetmic.2014.06.023","article-title":"A severe equine herpesvirus type 1 (EHV-1) abortion outbreak caused by a neuropathogenic strain at a breeding farm in northern Germany","volume":"172","author":"Damiani","year":"2014","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.09.106_b0040","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1586\/14760584.5.1.119","article-title":"Equine herpesvirus type 1 modified live virus vaccines: quo vaditis?","volume":"5","author":"Rosas","year":"2006","journal-title":"Expert Review of Vaccines."},{"key":"10.1016\/j.vaccine.2019.09.106_b0045","first-page":"124595","article-title":"Herpesvirus BACs: past, present, and future","volume":"2011","author":"Warden","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.vaccine.2019.09.106_b0050","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0264-410X(94)90122-8","article-title":"conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine","volume":"12","author":"Kaashoek","year":"1994","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2019.09.106_b0055","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.2460\/javma.1994.205.11.1581","article-title":"Eradication of pseudorabies virus from three large swine herds achieved by management intervention and use of a vaccine with a deletion for glycoprotein I","volume":"205","author":"Lehman","year":"1994","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.vaccine.2019.09.106_b0060","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1006\/viro.1997.8984","article-title":"An equine herpesvirus type 1 recombinant with a deletion in the gE and gI genes is avirulent in young horses","volume":"242","author":"Matsumura","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2019.09.106_b0065","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1292\/jvms.001439","article-title":"Equine herpesvirus type 1 mutant defective in glycoprotein E gene as candidate vaccine strain","volume":"71","author":"Tsujimura","year":"2009","journal-title":"J Veter Med Sci\/Jpn Soc Veter Sci."},{"key":"10.1016\/j.vaccine.2019.09.106_b0070","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12917-019-2036-0","article-title":"Epizootiological investigation of equine herpesvirus type 1 infection among Japanese racehorses before and after the replacement of an inactivated vaccine with a modified live vaccine","volume":"15","author":"Bannai","year":"2019","journal-title":"BMC Veter. Res."},{"key":"10.1016\/j.vaccine.2019.09.106_b0075","first-page":"1","article-title":"Alterations in the equine herpesvirus type-1 (EHV-1) strain RacH during attenuation","volume":"43","author":"Hubert","year":"1996","journal-title":"Zentralblatt fur Veterinarmedizin Reihe B J Veter Med Series B"},{"key":"10.1016\/j.vaccine.2019.09.106_b0080","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/BF01267802","article-title":"On the fine structure of a virus of the herpes group isolated from horses (short report)","volume":"13","author":"Reczko","year":"1963","journal-title":"Archiv fur Die Gesamte Virusforschung."},{"key":"10.1016\/j.vaccine.2019.09.106_b0085","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3389\/fvets.2017.00211","article-title":"Comparative Genomic Sequencing and Pathogenic Properties of Equine Herpesvirus 1 KyA and RacL11","volume":"4","author":"Shakya","year":"2017","journal-title":"Frontiers Veter Sci"},{"key":"10.1016\/j.vaccine.2019.09.106_b0090","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1751-0813.1992.tb07462.x","article-title":"The molecular epidemiology of equine herpesvirus 1 (equine abortion virus) in Australasia 1975 to 1989","volume":"69","author":"Studdert","year":"1992","journal-title":"Aust Vet J"},{"key":"10.1016\/j.vaccine.2019.09.106_b0095","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/tbed.12809","article-title":"Genetic diversity of equine herpesvirus 1 isolated from neurological, abortigenic and respiratory disease outbreaks","volume":"65","author":"Bryant","year":"2018","journal-title":"Transboundary Emerging Diseases"},{"key":"10.1016\/j.vaccine.2019.09.106_b0100","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1006\/viro.1996.0652","article-title":"The equine herpesvirus 1 IR6 protein influences virus growth at elevated temperature and is a major determinant of virulence","volume":"226","author":"Osterrieder","year":"1996","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2019.09.106_b0105","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1016\/j.vaccine.2006.01.062","article-title":"Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1)","volume":"24","author":"Goodman","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.09.106_b0110","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1016\/j.vaccine.2010.05.065","article-title":"Control of EHV-1 viremia and nasal shedding by commercial vaccines","volume":"28","author":"Goehring","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.09.106_b0115","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2746\/042516401776249318","article-title":"The mucosal humoral immune response of the horse to infective challenge and vaccination with equine herpesvirus-1 antigens","volume":"33","author":"Breathnach","year":"2001","journal-title":"Equine Vet J"},{"key":"10.1016\/j.vaccine.2019.09.106_b0120","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1099\/vir.0.19268-0","article-title":"Identification of equine herpesvirus-1 antigens recognized by cytotoxic T lymphocytes","volume":"84","author":"Soboll","year":"2003","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2019.09.106_b0125","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1099\/vir.0.82070-0","article-title":"A molecular approach to the identification of cytotoxic T-lymphocyte epitopes within equine herpesvirus 1","volume":"87","author":"Kydd","year":"2006","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2019.09.106_b0130","unstructured":"Ostlund EN, Allen, GP, Yeargan MR, Coogle LD. The antibody response of horses to specific antigenic domains on equid herpesvirus-1 glycoproteins B and C. In: W. Plowright PDR, J.F. Wade, editor. Equine Infectious Diseases VI. Cambridge: R&W Publications (Newmarket) Ltd; 2992. p. 277-82."},{"key":"10.1016\/j.vaccine.2019.09.106_b0135","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1128\/jvi.70.6.4110-4115.1996","article-title":"The equine herpesvirus 1 glycoprotein gp21\/22a, the herpes simplex virus type 1 gM homolog, is involved in virus penetration and cell-to-cell spread of virions","volume":"70","author":"Osterrieder","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.09.106_b0140","doi-asserted-by":"crossref","first-page":"8029","DOI":"10.1128\/JVI.01181-13","article-title":"Herpes simplex virus 1 glycoprotein M and the membrane-associated protein UL11 are required for virus-induced cell fusion and efficient virus entry","volume":"87","author":"Kim","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.09.106_b0145","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1006\/viro.1997.8857","article-title":"Equine herpesvirus 1 mutants devoid of glycoprotein B or M are apathogenic for mice but induce protection against challenge infection","volume":"239","author":"Neubauer","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2019.09.106_b0150","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0378-1135(01)00357-1","article-title":"Deletion of gene 52 encoding glycoprotein M of equine herpesvirus type 1 strain RacH results in increased immunogenicity","volume":"81","author":"Osterrieder","year":"2001","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.09.106_b0155","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1051\/vetres:2004019","article-title":"Equine viral vaccines: the past, present and future","volume":"35","author":"Minke","year":"2004","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2019.09.106_b0160","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF01317269","article-title":"Pathogenesis of equine herpesvirus-1 in specific pathogen-free foals: primary and secondary infections and reactivation","volume":"123","author":"Gibson","year":"1992","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2019.09.106_b0165","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.2460\/ajvr.1993.54.10.1608","article-title":"Microbiologic changes during antimicrobial treatment and rate of relapse of distal respiratory tract infections in foals","volume":"54","author":"Hoffman","year":"1993","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2019.09.106_b0170","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2746\/042516407X166954","article-title":"Evidence for transferrin allele as a host-level risk factor in naturally occurring equine respiratory disease: a preliminary study","volume":"39","author":"Newton","year":"2007","journal-title":"Equine Vet J"},{"key":"10.1016\/j.vaccine.2019.09.106_b0175","unstructured":"American Association of Equine Practitioners A. Risk-based vaccination guidelines. Equine herpesvirus (Rhinopneumonitis). 2019."},{"key":"10.1016\/j.vaccine.2019.09.106_b0180","unstructured":"OIE World Organisation for Animal Health. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. 2019."},{"key":"10.1016\/j.vaccine.2019.09.106_b0185","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.2042-3306.1976.tb03291.x","article-title":"Serological detection of equid herpesvirus 1 infections of the respiratory tract","volume":"8","author":"Thomson","year":"1976","journal-title":"Equine Vet J"},{"key":"10.1016\/j.vaccine.2019.09.106_b0190","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.vetimm.2005.06.009","article-title":"The use of a systemic prime\/mucosal boost strategy with an equine influenza ISCOM vaccine to induce protective immunity in horses","volume":"108","author":"Crouch","year":"2005","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2019.09.106_b0195","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1128\/jvi.69.1.606-612.1995","article-title":"Major histocompatibility complex class I-restricted cytotoxic T-lymphocyte responses in horses infected with equine herpesvirus 1","volume":"69","author":"Allen","year":"1995","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.09.106_b0200","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1016\/S0264-410X(01)00131-1","article-title":"Clinical and virological evaluation of the efficacy of an inactivated EHV1 and EHV4 whole virus vaccine (Duvaxyn EHV-1,4). Vaccination\/challenge experiments in foals and pregnant mares","volume":"19","author":"Heldens","year":"2001","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2019.09.106_b0205","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.vetimm.2006.01.008","article-title":"Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination","volume":"111","author":"Minke","year":"2006","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2019.09.106_b0210","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.vaccine.2009.10.123","article-title":"A vectored equine herpesvirus type 1 (EHV-1) vaccine elicits protective immune responses against EHV-1 and H3N8 equine influenza virus","volume":"28","author":"Van de Walle","year":"2010","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2019.09.106_b0215","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.vetmic.2018.06.015","article-title":"Comparison of protective efficacies between intranasal and intramuscular vaccination of horses with a modified live equine herpesvirus type-1 vaccine","volume":"222","author":"Bannai","year":"2018","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.09.106_b0220","unstructured":"Horserace Betting Levy Board H. Codes of Practice, Equine herpesvirus. 2019."},{"key":"10.1016\/j.vaccine.2019.09.106_b0225","doi-asserted-by":"crossref","first-page":"620","DOI":"10.2746\/042516403775467153","article-title":"Onset of immunoglobulin production in foals","volume":"35","author":"Holznagel","year":"2003","journal-title":"Equine Vet J"},{"key":"10.1016\/j.vaccine.2019.09.106_b0230","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0165-2427(00)00149-5","article-title":"Characterization of peripheral blood and pulmonary leukocyte function in healthy foals","volume":"73","author":"Flaminio","year":"2000","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2019.09.106_b0235","doi-asserted-by":"crossref","first-page":"e0120661","DOI":"10.1371\/journal.pone.0120661","article-title":"Regulatory T cells in early life: comparative study of CD4+CD25+high T cells from foals and adult horses","volume":"10","author":"Hamza","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.09.106_b0240","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1439-0442.1992.tb00157.x","article-title":"Development of lymphocyte blastogenic response in the neonatal period of foals","volume":"39","author":"Sanada","year":"1992","journal-title":"Zentralbl Veterinarmed [A]"},{"key":"10.1016\/j.vaccine.2019.09.106_b0245","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.2042-3306.1991.tb04755.x","article-title":"Haematological changes and equine lymphocyte subpopulation kinetics during primary infection and attempted re-infection of specific pathogen free foals with EHV-1","volume":"23","author":"Lunn","year":"1991","journal-title":"Equine Vet J"},{"key":"10.1016\/j.vaccine.2019.09.106_b0250","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.vetimm.2009.06.010","article-title":"Effect of age and mitogen on the frequency of interleukin-4 and interferon gamma secreting cells in foals and adult horses as assessed by an equine-specific ELISPOT assay","volume":"133","author":"Ryan","year":"2010","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2019.09.106_b0255","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.vetimm.2006.02.010","article-title":"Foals are interferon gamma-deficient at birth","volume":"112","author":"Breathnach","year":"2006","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2019.09.106_b0260","doi-asserted-by":"crossref","first-page":"676","DOI":"10.2746\/042516401776249327","article-title":"Neutrophil functions and serum IgG in growing foals","volume":"33","author":"Demmers","year":"2001","journal-title":"Equine Vet J"},{"key":"10.1016\/j.vaccine.2019.09.106_b0265","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.2460\/ajvr.2000.61.1099","article-title":"Immunoglobulin isotypes in sera and nasal mucosal secretions and their neonatal transfer and distribution in horses","volume":"61","author":"Sheoran","year":"2000","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2019.09.106_b0270","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1128\/CVI.05522-11","article-title":"Immunological correlates of vaccination and infection for equine herpesvirus 1","volume":"19","author":"Goodman","year":"2012","journal-title":"Clin Vac Immunol: CVI"},{"key":"10.1016\/j.vaccine.2019.09.106_b0275","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/evj.12387","article-title":"The development of equine immunity: Current knowledge on immunology in the young horse","volume":"47","author":"Perkins","year":"2015","journal-title":"Equine Vet J"},{"key":"10.1016\/j.vaccine.2019.09.106_b0280","doi-asserted-by":"crossref","first-page":"e0177831","DOI":"10.1371\/journal.pone.0177831","article-title":"Antigen-specific immunoglobulin variable region sequencing measures humoral immune response to vaccination in the equine neonate","volume":"12","author":"Tallmadge","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.09.106_b0285","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1128\/CVI.00328-10","article-title":"Equine neonates have attenuated humoral and cell-mediated immune responses to a killed adjuvanted vaccine compared to adult horses","volume":"17","author":"Ryan","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2019.09.106_b0290","doi-asserted-by":"crossref","first-page":"644","DOI":"10.2746\/042516401776249435","article-title":"Passive transfer of maternal immunoglobulin isotype antibodies against tetanus and influenza and their effect on the response of foals to vaccination","volume":"33","author":"Wilson","year":"2001","journal-title":"Equine Vet J"},{"key":"10.1016\/j.vaccine.2019.09.106_b0295","doi-asserted-by":"crossref","first-page":"e0169072","DOI":"10.1371\/journal.pone.0169072","article-title":"Neonatal immunization with a single IL-4\/antigen dose induces increased antibody responses after challenge infection with equine herpesvirus type 1 (EHV-1) at weanling age","volume":"12","author":"Wagner","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.09.106_b0300","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/acel.12326","article-title":"How sex and age affect immune responses, susceptibility to infections, and response to vaccination","volume":"14","author":"Giefing-Kroll","year":"2015","journal-title":"Aging Cell"},{"key":"10.1016\/j.vaccine.2019.09.106_b0305","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJM199710163371601","article-title":"Herpes simplex virus type 2 in the United States, 1976 to 1994","volume":"337","author":"Fleming","year":"1997","journal-title":"New Engl J Med"},{"key":"10.1016\/j.vaccine.2019.09.106_b0310","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1473-3099(03)00857-0","article-title":"What does epidemiology tell us about risk factors for herpes zoster?","volume":"4","author":"Thomas","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2019.09.106_b0315","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/nri2394","article-title":"The X-files in immunity: sex-based differences predispose immune responses","volume":"8","author":"Fish","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2019.09.106_b0320","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1530\/eje.0.1430031","article-title":"Consistent production of a higher TH1:TH2 cytokine ratio by stimulated T cells in men compared with women","volume":"143","author":"Giron-Gonzalez","year":"2000","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.vaccine.2019.09.106_b0325","first-page":"6","article-title":"Rodriguez Perez Mdel C, Hernandez AG, Chico BN, de Leon AC. Sex hormones and autoimmunity","volume":"133","author":"Gonzalez","year":"2010","journal-title":"Immunol Lett"},{"key":"10.1016\/j.vaccine.2019.09.106_b0330","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0749-0739(17)30465-0","article-title":"Endocrine and testicular changes associated with season, artificial photoperiod, and the peri-pubertal period in stallions","volume":"8","author":"Clay","year":"1992","journal-title":"Vet Clin North Am Equine Pract"},{"key":"10.1016\/j.vaccine.2019.09.106_b0335","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.theriogenology.2019.04.014","article-title":"Age related and seasonal changes of plasma concentrations of insulin-like peptide 3 and testosterone from birth to early-puberty in Thoroughbred male horses","volume":"132","author":"Hannan","year":"2019","journal-title":"Theriogenology"},{"key":"10.1016\/j.vaccine.2019.09.106_b0340","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.theriogenology.2018.07.026","article-title":"Intrafollicular level of steroid hormones and the expression of androgen receptor in the equine ovary at puberty","volume":"121","author":"Mlodawska","year":"2018","journal-title":"Theriogenology"},{"key":"10.1016\/j.vaccine.2019.09.106_b0345","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.vetimm.2011.06.032","article-title":"Infection of peripheral blood mononuclear cells with neuropathogenic equine herpesvirus type-1 strain Ab4 reveals intact interferon-alpha induction and induces suppression of anti-inflammatory interleukin-10 responses in comparison to other viral strains","volume":"143","author":"Wagner","year":"2011","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2019.09.106_b0350","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1297-9716-42-23","article-title":"Evaluation of immune responses following infection of ponies with an EHV-1 ORF1\/2 deletion mutant","volume":"42","author":"Soboll Hussey","year":"2011","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2019.09.106_b0355","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s12917-018-1563-4","article-title":"Deletion of the ORF2 gene of the neuropathogenic equine herpesvirus type 1 strain Ab4 reduces virulence while maintaining strong immunogenicity","volume":"14","author":"Schnabel","year":"2018","journal-title":"BMC Veterinary Research."},{"key":"10.1016\/j.vaccine.2019.09.106_b0360","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1128\/JVI.06994-11","article-title":"Identification and characterization of equine herpesvirus type 1 pUL56 and its role in virus-induced downregulation of major histocompatibility complex class I","volume":"86","author":"Ma","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.09.106_b0365","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.1128\/JVI.00032-15","article-title":"Equine Herpesvirus 1 Multiply Inserted Transmembrane Protein pUL43 Cooperates with pUL56 in Downregulation of Cell Surface Major Histocompatibility Complex Class I","volume":"89","author":"Huang","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.09.106_b0370","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.4049\/jimmunol.1103434","article-title":"Host genetic factors in susceptibility to herpes simplex type 1 virus infection: contribution of polymorphic genes at the interface of innate and adaptive immunity","volume":"188","author":"Moraru","year":"2012","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"key":"10.1016\/j.vaccine.2019.09.106_b0375","article-title":"Therapeutic vaccine against HIV, viral variability, cytotoxic T lymphocyte epitopes, and genetics of patients","author":"Fleury","year":"2017","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.vaccine.2019.09.106_b0380","doi-asserted-by":"crossref","first-page":"13124","DOI":"10.1128\/JVI.02250-13","article-title":"Tetherin restricts herpes simplex virus 1 and is antagonized by glycoprotein M","volume":"87","author":"Blondeau","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.09.106_b0385","first-page":"220","article-title":"Comparison of bovine herpesvirus 1 vaccines for rapid induction of immunity","volume":"1","author":"Roth","year":"2000","journal-title":"Veter Ther: Res in Appl Veter Med"},{"key":"10.1016\/j.vaccine.2019.09.106_b0390","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0007-1935(05)80061-2","article-title":"Response of ponies to adjuvanted EHV-1 whole virus vaccine and challenge with virus of the homologous strain","volume":"151","author":"Dolby","year":"1995","journal-title":"British Veter J"},{"key":"10.1016\/j.vaccine.2019.09.106_b0395","article-title":"Mucosal vaccination via the respiratory","volume":"11","author":"Hellfritzsch","year":"2019","journal-title":"Tract Pharm"},{"key":"10.1016\/j.vaccine.2019.09.106_b0400","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.smim.2018.05.001","article-title":"Correlates of adjuvanticity: A review on adjuvants in licensed vaccines","volume":"39","author":"Del Giudice","year":"2018","journal-title":"Semin Immunol"},{"key":"10.1016\/j.vaccine.2019.09.106_b0405","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1146\/annurev.physiol.70.113006.100702","article-title":"Structure and function of the polymeric mucins in airways mucus","volume":"70","author":"Thornton","year":"2008","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.vaccine.2019.09.106_b0410","doi-asserted-by":"crossref","first-page":"e19678","DOI":"10.1371\/journal.pone.0019678","article-title":"Muc5b is the major polymeric mucin in mucus from Thoroughbred horses with and without airway mucus accumulation","volume":"6","author":"Rousseau","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.09.106_b0415","doi-asserted-by":"crossref","first-page":"e51054","DOI":"10.1371\/journal.pone.0051054","article-title":"Immobilization of pseudorabies virus in porcine tracheal respiratory mucus revealed by single particle tracking","volume":"7","author":"Yang","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.09.106_b0420","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1084\/jem.20020400","article-title":"Receptor-mediated immunoglobulin G transport across mucosal barriers in adult life: functional expression of FcRn in the mammalian lung","volume":"196","author":"Spiekermann","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2019.09.106_b0425","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/path.1877","article-title":"The function of immunoglobulin A in immunity","volume":"208","author":"Woof","year":"2006","journal-title":"J Pathol"},{"key":"10.1016\/j.vaccine.2019.09.106_b0430","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.molimm.2007.06.158","article-title":"The different effector function capabilities of the seven equine IgG subclasses have implications for vaccine strategies","volume":"45","author":"Lewis","year":"2008","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2019.09.106_b0435","doi-asserted-by":"crossref","first-page":"16656","DOI":"10.1038\/s41598-017-16804-5","article-title":"Access to a main alphaherpesvirus receptor, located basolaterally in the respiratory epithelium, is masked by intercellular junctions","volume":"7","author":"Van Cleemput","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2019.09.106_b0440","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1586\/14760584.2015.1081067","article-title":"Effect of vaccine administration modality on immunogenicity and efficacy","volume":"14","author":"Zhang","year":"2015","journal-title":"Expert Rev. Vac."},{"key":"10.1016\/j.vaccine.2019.09.106_b0445","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.vetimm.2006.01.014","article-title":"Detection of equine herpesvirus-specific effector and memory cytotoxic immunity in the equine upper respiratory tract","volume":"111","author":"Breathnach","year":"2006","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2019.09.106_b0450","unstructured":"Jessett DM, Schrag, D., Mumford, J.A. Protection provided by an attenuated EHV-1 vaccine against challenge with the virulent EHV-1 Ab4 isolate. In: U. Wernery JFW, O-R Kaaden, editor. Equine Infectious Diseases VIII. Dubai: R&W Publications (Newmarket) Ltd.; 1999. p. 414."},{"key":"10.1016\/j.vaccine.2019.09.106_b0455","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.vetimm.2006.01.010","article-title":"Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus","volume":"111","author":"Holmes","year":"2006","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2019.09.106_b0460","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF01309846","article-title":"Modulation of the serological response of specific pathogen-free (EHV-free) foals to EHV-1 by previous infection with EHV-4 or a TK-deletion mutant of EHV-1","volume":"132","author":"Tewari","year":"1993","journal-title":"Arch Virol"},{"issue":"Pt 5","key":"10.1016\/j.vaccine.2019.09.106_b0465","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1099\/0022-1317-74-5-819","article-title":"Pathogenicity of a thymidine kinase-deficient mutant of equine herpesvirus 1 in mice and specific pathogen-free foals","volume":"74","author":"Slater","year":"1993","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2019.09.106_b0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1135(02)00358-9","article-title":"Equid herpesvirus (EHV-1) live vaccine strain C147: efficacy against respiratory diseases following EHV types 1 and 4 challenges","volume":"92","author":"Patel","year":"2003","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.09.106_b0475","first-page":"260","article-title":"Safety and efficacy of a thymidine kinase negative equine herpesvirus-1 vaccine in young horses","volume":"54","author":"Cornick","year":"1990","journal-title":"Candadian J Veter Res"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1931360X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1931360X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:37:51Z","timestamp":1759401471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1931360X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":95,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0264410X1931360X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.09.106","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccination of foals with a modified live, equid herpesvirus-1 gM deletion mutant (RacH\u0394gM) confers partial protection against infection","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.09.106","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}